Telix Pharmaceuticals Ltd. (TLX)

9.43 +0.21 (+2.28%) USD  |  NASDAQ  |  Jun 09, 16:00
9.43 0.00 (0.00%) After-Hours: 20:00
More

Telix Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for TLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Propanc Biopharma, Inc. Upgrade
Mesoblast Ltd. Upgrade
Amplia Therapeutics Ltd. Upgrade
Agenus, Inc. Upgrade